Jones, N; Vogt, S; Nielsen, M; Christian, D; Wark, PA; Eccles, D; Edwards, E; Evans, DG; Maher, ER; Vasen, HF; +3 more... Hes, FJ; Aretz, S; Sampson, JR; (2009) Increased Colorectal Cancer Incidence in Obligate Carriers of Heterozygous Mutations in MUTYH. Gastroenterology, 137 (2). pp. 489-494. ISSN 0016-5085 DOI: https://doi.org/10.1053/j.gastro.2009.04.047 Full text not available from this repository.

Reis-Filho, JS; Drury, S; Lambros, MB; Marchio, C; Johnson, N; Natrajan, R; Salter, J; Levey, P; Fletcher, O; Peto, J; +2 more... Ashworth, A; Dowsett, M; (2008) ESR1 gene amplification in breast cancer: a common phenomenon? Nature genetics, 40 (7). pp. 809-810. ISSN 1061-4036 DOI: https://doi.org/10.1038/ng0708-809b Full text not available from this repository.

Alharbi, KK; Spanakis, E; Tan, K; Smith, MJ; Aldahmesh, MA; O'Dell, SD; Sayer, AA; Lawlor, DA; Ebrahim, S; Smith, GD; +5 more... O'Rahilly, S; Farooqi, S; Cooper, C; Phillips, DIW; Day, INM; (2007) Prevalence and functionality of paucimorphic and private MC4R mutations in a large, unselected European British population, scanned by meltMADGE. Human mutation, 28 (3). pp. 294-302. ISSN 1059-7794 DOI: https://doi.org/10.1002/humu.20404 Full text not available from this repository.

Smith, R; Raithatha, N; (2006) Why disclosure of genetic tests for health insurance should be voluntary. Journal of health services research & policy, 11 (3). pp. 184-6. ISSN 1355-8196 DOI: https://doi.org/10.1258/135581906777641730 Full text not available from this repository.

Raithatha, N; Smith, RD; (2004) Disclosure of genetic tests for health insurance: is it ethical not to? Lancet, 363 (9406). pp. 395-6. ISSN 0140-6736 DOI: https://doi.org/10.1016/S0140-6736(04)15442-1 Full text not available from this repository.

Meijers-Heijboer, H; van Den Ouweland, A; Klijn, J; Wasielewski, M; de Snoo, A; Oldenburg, R; Hollestelle, A; Houben, M; Crepin, E; van Veghel-Plandsoen, M; +31 more... Elstrodt, F; van Duijn, C; Bartels, C; Meijers, C; Schutte, M; McGuffog, L; Thompson, D; Easton, DF; Sodha, N; Seal, S; Barfoot, R; Mangion, J; Chang-Claude, J; Eccles, D; Eeles, R; Evans, DG; Houlston, R; Murday, V; Narod, S; Peretz, T; Peto, J; Phelan, C; Zhang, HX; Szabo, C; Devilee, P; Goldgar, D; Futreal, PA; Nathanson, KL; Weber, BL; Rahman, N; Stratton, MR; (2002) Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations. Nature genetics, 31 (1). pp. 55-59. ISSN 1061-4036 DOI: https://doi.org/10.1038/ng879 Full text not available from this repository.

Omar, SA; Adagu, IS; Warhurst, DC; (2001) Can pretreatment screening for dhps and dhfr point mutations in Plasmodium falciparum infections be used to predict sulfadoxine-pyrimethamine treatment failure? Transactions of the Royal Society of Tropical Medicine and Hygiene, 95 (3). pp. 315-9. ISSN 0035-9203 https://researchonline.lshtm.ac.uk/id/eprint/16300 Full text not available from this repository.

Vineis, P; Schulte, P; McMichael, AJ; (2001) Misconceptions about the use of genetic tests in populations. Lancet, 357 (9257). pp. 709-12. ISSN 0140-6736 DOI: https://doi.org/10.1016/S0140-6736(00)04136-2 Full text not available from this repository.

Whitwell, JL; Crum, WR; Watt, HC; Fox, NC; (2001) Normalization of cerebral volumes by use of intracranial volume: implications for longitudinal quantitative MR imaging. AJNR American journal of neuroradiology, 22 (8). pp. 1483-9. ISSN 0195-6108 https://researchonline.lshtm.ac.uk/id/eprint/15442 Full text not available from this repository.